162 related articles for article (PubMed ID: 32635818)
1. A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.
Roche E; Pons R; Roche O; Puig A
Phlebology; 2020 Oct; 35(9):724-733. PubMed ID: 32635818
[TBL] [Abstract][Full Text] [Related]
2. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
Star P; Connor DE; Parsi K
Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
4. Generation of sclerosant foams by mechanical methods increases the foam temperature.
Tan L; Wong K; Connor D; Fakhim B; Behnia M; Parsi K
Phlebology; 2017 Aug; 32(7):501-505. PubMed ID: 27738239
[TBL] [Abstract][Full Text] [Related]
5. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
Rao J; Goldman MP
Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
[TBL] [Abstract][Full Text] [Related]
6. Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.
Watkins MR; Oliver RJ
Phlebology; 2017 Jul; 32(6):390-396. PubMed ID: 27329670
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
8. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
[TBL] [Abstract][Full Text] [Related]
9. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
[TBL] [Abstract][Full Text] [Related]
11. Polidocanol for endovenous microfoam sclerosant therapy.
Eckmann DM
Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
[TBL] [Abstract][Full Text] [Related]
12. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
13. The effect of the calibre and length of needle on the stability of sclerosing foam.
Skuła M; Hobot J; Czaja J; Simka M
Phlebology; 2021 May; 36(4):322-328. PubMed ID: 33236673
[TBL] [Abstract][Full Text] [Related]
14. Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate.
Wong K; Connor DE; Andrade OC; Parsi K
Phlebology; 2021 Aug; 36(7):576-587. PubMed ID: 33736561
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulodexide on stability of sclerosing foams.
Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R
Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533
[TBL] [Abstract][Full Text] [Related]
16. Microfoam sclerotherapy.
Redondo P; Cabrera J
Semin Cutan Med Surg; 2005 Dec; 24(4):175-83. PubMed ID: 16387261
[TBL] [Abstract][Full Text] [Related]
17. Sclerosant foam structure and stability is strongly influenced by liquid air fraction.
Cameron E; Chen T; Connor DE; Behnia M; Parsi K
Eur J Vasc Endovasc Surg; 2013 Oct; 46(4):488-94. PubMed ID: 23993276
[TBL] [Abstract][Full Text] [Related]
18. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Rao J; Wildemore JK; Goldman MP
Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
[TBL] [Abstract][Full Text] [Related]
19. Significant endothelin release in patients treated with foam sclerotherapy.
Frullini A; Barsotti MC; Santoni T; Duranti E; Burchielli S; Di Stefano R
Dermatol Surg; 2012 May; 38(5):741-7. PubMed ID: 22540861
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and optimisation of foams for varicose vein sclerotherapy.
Roberts TG; Cox SJ; Lewis AL; Jones SA
Biorheology; 2020; 57(2-4):77-85. PubMed ID: 33459690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
